Pooled Analysis of 86 Published Spinal Hydatid Cyst Cases From Turkey
Journal Title: Mediterranean Journal of Infection, Microbes and Antimicrobials - Year 2019, Vol 8, Issue 1
Abstract
Introduction: Spinal hydatid cyst (SHC) is a difficult to treat parasitic infectious disease with high risk of recurrence. Similar with HC the visceral organs, there are no standard treatment protocols for SHC. The aim of this study was to analyze clinical and laboratory findings, treatment, and prognosis in published SHC case reports from Turkey in the last 20 years. Materials and Methods: One national (Ulakbim, Turkish medical literature database, http://uvt.ulakbim.gov.tr/uvt/) and two international databases (www.scopus.com and www.pubmed.com) were searched for SHC case reports from Turkey published in Turkish and international journals between January 1998 and November 2018. Relevant articles were identified using the keywords “spinal kist hidatik” and “vertebral kist hidatik” in the national database and “spinal hydatid cyst and Turkey” and “vertebral hydatid cyst and Turkey” in the international databases. Of 114 articles identified in the initial search, 55 articles that met the study criteria were included in our analysis. The cases were evaluated in terms of presenting symptoms, history, physical examination findings, concurrent extraspinal involvement, diagnostic methods, spinal lesion category, treatment, and prognosis. Results: A total of 86 cases of SHC were identified in the three databases using the specified keywords. Forty-eight (56%) of the patients were male and the mean age was 36.4±16.8 (8-73) years. The most common presenting symptoms were back pain (83%), difficulty in walking (47%), urinary and/or stool incontinence (27%), and leg numbness (22%). Concurrent extraspinal involvement was identified in 35% of the patients while thoracic involvement was the most common (36%). Extradural intraspinal was the most common lesion type. The most preferred treatment protocol was albendazole for a duration of six months. When the history and follow-up period of the patients were evaluated together, 51% of the patients had at least one recurrence. Conclusion: SHC affects the young to middle-aged population, leading to neurological morbidities that decrease patients’ quality of life. Studies are needed to determine more effective medical treatment protocols for SHC.
Authors and Affiliations
Bedia Mutay SUNTUR, Gökhan ÇAVUŞ
Keywords
Related Articles
- EP ID EP689268
- DOI 10.4274/mjima.galenos.2019.2019.7
- Views 184
- Downloads 0
Chronic Hepatitis C Treatment with New Antiviral Agents
Recent advances in our knowledge of hepatitis C virus (HCV) molecular biology have enabled improvements in the efficacy and tolerability of HCV treatment, and in this regard many direct-acting antiviral (DAA) agents have...
Hantavirus Infections in Light of Current Knowledge
Hantavirus is an enveloped virus with an RNA genome comprised of three negative-sense, single-stranded segments and belongs to the genus Hantavirus in family Bunyaviridae. Human infections are seen in two different clini...
An Unusual Case of Orf with Erythema Multiforme and Vesiculo-bullous Lesions after Eid al-Adha
No Abstract
Not So Innocent: Thrombocytopenia After One Dose of Rifampicin
No Abstract
Evaluation of Risk Factors Associated with HBsAg and Anti-HCV Seropositivity: Results of a Nationwide Population-based Epidemiological Survey Study in Turkey
Introduction: In this study, it was aimed to evaluate factors associated with hepatitis B surface antigen (HBsAg) and anti-hepatitis C virus (HCV) positivity through the “Raising Public Awareness and Determining Epidemio...